Sada Sharada Tumor And Research Institute
Hospital and research institute established in 1989 in Karnataka.
1989 | Karnataka, Karnataka (India) | Active
Sada Sharada Tumor And Research Institute Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
- Paid Up Capital ₹ 5.98 Cr
- Company Age 36 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.25 Cr
- Satisfied Charges ₹ 4.70 M
- Revenue Growth 26.34%
- Profit Growth -20.14%
- Ebitda 114.75%
- Net Worth 22.23%
- Total Assets 12.86%
About Sada Sharada Tumor And Research Institute
Sada Sharada Tumor And Research Institute (SSTARI) is a leading Public Not For Profit Company incorporated in India on 20 February 1989 and has a history of 36 years and one month. Its registered office is in Karnataka, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 5.98 Cr.
The company currently has active open charges totaling ₹4.25 Cr. The company has closed loans amounting to ₹4.70 M, as per Ministry of Corporate Affairs (MCA) records.
Anjali Ajaikumar, Basavlinga Amarkumar, Bhagya Ajaikumar, and One other member serve as directors at the Company.
Company Details
- Location
Karnataka, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85110KA1989NPL009862
- Company No.
009862
- Company Classification
Public Not For Profit Company
- Incorporation Date
20 Feb 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Healthcare
Who are the key members and board of directors at Sada Sharada Tumor And Research Institute?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anjali Ajaikumar  | Director | 19-Mar-2018 | Current |
| Basavlinga Amarkumar | Director | 20-Feb-1989 | Current |
Bhagya Ajaikumar  | Director | 30-Sep-1993 | Current |
| Basavalinga Sadasivaiah | Director | 20-Feb-1989 | Current |
Financial Performance of Sada Sharada Tumor And Research Institute.
Sada Sharada Tumor And Research Institute, for the financial year ended 2023, experienced significant growth in revenue, with a 26.34% increase. The company also saw a substantial fall in profitability, with a 20.14% decrease in profit. The company's net worth Soared by an impressive increase of 22.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sada Sharada Tumor And Research Institute?
In 2023, Sada Sharada Tumor And Research Institute had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gha Global Healthcare Academy Private LimitedBasavalinga Sadasivaiah is a mutual person
Equator Games LlpAnjali Ajaikumar is a mutual person
Vizag Hospital And Cancer Research Centre Pvt LtdBasavalinga Sadasivaiah is a mutual person
Bacc Health Care Private LimitedAnjali Ajaikumar and Basavalinga Sadasivaiah are mutual person
Suchirayu Health Care Solutions LimitedAnjali Ajaikumar and Basavalinga Sadasivaiah are mutual person
International Stemcell Services LimitedBasavalinga Sadasivaiah is a mutual person
Charges (Loans)
Open Charges
₹4.25 Cr
Satisfied Charges
₹0.47 Cr
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 4.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Mar 2023 | Yes Bank Limited | ₹4.25 Cr | Open |
| 26 Nov 2013 | Syndicate Bank | ₹4.70 M | Satisfied |
How Many Employees Work at Sada Sharada Tumor And Research Institute?
Sada Sharada Tumor And Research Institute has a workforce of 260 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sada Sharada Tumor And Research Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sada Sharada Tumor And Research Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Sada Sharada Tumor And Research Institute
Recent activity within the organization
- Annual General Meeting
Sada Sharada Tumor And Research Institute last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Sada Sharada Tumor And Research Institute has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore.
- Charges
A charge with Yes Bank Limited amounted to Rs. 4.25 Cr with Charge ID 100687089 was registered on 14 Mar 2023.
- Charges
A charge registered on 26 Nov 2013 via Charge ID 10463010 with Syndicate Bank was fully satisfied on 28 Oct 2022.
- Director Appointment
Anjali Rossi Ajaikumar was appointed as a Director was appointed as a Director on 19 Mar 2018 & has been associated with this company since 7 years 10 days .
- Charges
A charge with Syndicate Bank amounted to Rs. 0.47 Cr with Charge ID 10463010 was registered on 26 Nov 2013.
Frequently asked questions
What is the Incorporation or founding date of Sada Sharada Tumor And Research Institute?
Sada Sharada Tumor And Research Institute was incorporated on 20 Feb 1989.
What is authorized share capital and paid-up capital of Sada Sharada Tumor And Research Institute?
The authorized share capital of Sada Sharada Tumor And Research Institute is ₹ 6.00 Cr and paid-up capital is ₹ 5.98 Cr.
Who are the current board members & directors of Sada Sharada Tumor And Research Institute?
Currently 4 directors are associated with Sada Sharada Tumor And Research Institute.
- Anjali Rossi Ajaikumar
- Basavlinga Amarkumar
- Bhagya Adaveesh Ajaikumar
- Basavalinga Ajaikumar Sadasivaiah
What is the registered address of Sada Sharada Tumor And Research Institute?
As per Ministry of Corporate Affairs (Mca), the registered address of Sada Sharada Tumor And Research Institute is 438 Hebbal Areamysore Karnataka, India, 560017.
What is the corporate identification number (CIN) and company number of Sada Sharada Tumor And Research Institute?
The corporate identification number (CIN) of Sada Sharada Tumor And Research Institute is U85110KA1989NPL009862 and the company number is 009862 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Sada Sharada Tumor And Research Institute?
According to the financial reports for the fiscal year 2023, the revenue trend for Sada Sharada Tumor And Research Institute has risen by 26.34%.
How many employees does Sada Sharada Tumor And Research Institute currently have?
As Per 2023 financial reports, 260 employees are currently employed by Sada Sharada Tumor And Research Institute.
What change has been observed in the net worth of Sada Sharada Tumor And Research Institute, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Sada Sharada Tumor And Research Institute has experienced an upsurge of 22.23%.
What are the total open charges for Sada Sharada Tumor And Research Institute?
As per the financial statements for fiscal Year 2023, The total open charges for Sada Sharada Tumor And Research Institute amount to ₹ 4.25 Cr.
When was the last Balance Sheet of Sada Sharada Tumor And Research Institute filed with the ROC?
The most recent Balance Sheet for Sada Sharada Tumor And Research Institute was filed with the ROC on 31 Mar 2023.